guideSEQ: Genomic Understanding, Impact, Decision & Ethics in Prenatal Sequencing
Columbia University · with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NCT07610590
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 1042
- US sites recruiting
- 1
- Study start
- April 29, 2026
- Record last updated
- July 15, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study looks at whether genome sequencing should be used more routinely during pregnancy, even when ultrasounds look normal. Genome sequencing can examine nearly all of a baby's genes and may find genetic conditions that standard tests do not detect. Researchers will compare this test with current prenatal testing to see if it provides helpful information for families and doctors. The study will also explore how parents decide what kinds of genetic information they want to receive and how this information affects their experience during pregnancy. The goal is to understand whether genome sequencing can be used in a way that is helpful, responsible, and supportive for families in the future.
Being studied: Genome Sequencing (GS)
Conditions: Prenatal Genetic Diagnosis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Patient planned chorionic villus sampling (CVS) or amniocentesis in the absence of major fetal structural anomalies (minor anomalies are eligible, the HPO (Human Phenotype Ontology) will not be used by the analyst)
- Certified genetic counselor involved in care
Exclusion Criteria
- A major structural anomaly
- Maternal or paternal age less than 18 years old
- Parental unwillingness to participate in 1 year of postnatal follow-up
- Language barrier (non-English or Spanish speaking)
Recruiting US locations
Columbia University Irving Medical Center (CUIMC)
New York, NY 10032
Site contact: Camila Zarate, MPH · 646-300-0197 · cz2888@cumc.columbia.edu
Study contacts (from the official record)
- Camila Zarate, MPH · 646-300-0197 · cz2888@cumc.columbia.edu
- Jessica Giordano, MS, CGC · 516-521-5604 · jlg2197@cumc.columbia.edu
Similar studies in New York
All pregnancy studies in New York →- RecruitingHealthy volunteersEarly Phase 1
Predictors of Aspirin Failure in Preeclampsia Prevention
Rockefeller University
- Location
- New York, NY
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteers
Integration of the Oura Ring and Maven Clinic Among Women Who Are Trying to Conceive
Ouraring Inc.
- Location
- New York, NY
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteersPhase 3
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Pfizer
- Location
- Flushing, NY + 111 other US sites
- Eligibility basics
- Ages 0 mo–49
- RecruitingHealthy volunteers
A Study to Learn About the Safety of PENBRAYA During Pregnancy
Pfizer
- Location
- New York, NY
- Eligibility basics
- Ages 10–25 · Women only